RCEL
AVITA Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$11.20
+2.38%Year over year
Reported trailing growth
- Revenue
- +1.0%
- EBITDA
- +22.9%
- EBIT
- +24.6%
- EPS
- +26.4%
- Free cash flow
- +43.9%
- Operating cash flow
- +32.4%
Forward estimates
Based on analyst estimates
- Revenue
- +31.2%
- EBITDA
- +62.6%
- EPS
- +46.9%
Three-year CAGR
- Revenue
- +27.7%
- EBITDA
- +25.5%
- EBIT
- +24.8%
- Net income
- +21.4%
- EPS
- +27.2%
- Free cash flow
- +43.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026